trial-readout-analysis
FeaturedClinical-trial readout analysis: pull the trial, evaluate the readout with AdCom-style scrutiny (endpoints, statistics, subgroups, missing data, safety), and size the stock reaction with historical grounding. The judgment core for binary biotech events.
Install
Quality Score: 94/100
Skill Content
Details
- Author
- agentii-ai
- Repository
- agentii-ai/agentii-investment-intelligence
- Created
- 4 months ago
- Last Updated
- today
- Language
- Python
- License
- Apache-2.0
Similar Skills
Semantically similar based on skill content — not just same category
clinical-research
When the user wants to design, build, or operate clinical research informatics tools and workflows. Use when the user mentions "clinical trial," "clinical research," "RCT," "observational study," "registry study," "pragmatic trial," "real-world evidence," "RWE," "decentralized clinical trial," "DCT," "EDC," "REDCap," "Medidata Rave," "Veeva Vault EDC," "Castor," "OpenClinica," "CDISC," "CDASH," "SDTM," "ADaM," "Define-XML," "SEND," "eSource," "eCRF," "IRB," "single IRB," "sIRB," "Common Rule," "Belmont Report," "21 CFR Part 50," "21 CFR Part 56," "GCP," "ICH E6," "ICH E2B," "SAE," "SUSAR," "IWRS," "IRT," "randomization," "eConsent," "ePRO," "eCOA," "CTMS," "Veeva CTMS," "Florence eBinders," "ClinicalTrials.gov," or "FDAAA 801." For HIPAA Authorization vs. waiver mechanics, see hipaa-compliance. For 21 CFR Part 11 e-records / e-signatures, see 21-cfr-part-11. For trial-related FHIR integration with EHRs, see fhir-integration.
fda-catalyst-analysis
Dated FDA catalyst calendar (PDUFA target dates, AdCom meetings, device decisions, trial readouts, earnings) with AdCom-style scrutiny outcome framing and historical-case grounding. The FDA decision is the strongest stock catalyst in med.medicines_biotech — use this skill to enumerate, verify, and size upcoming catalysts for any biotech/pharma ticker or watchlist.
ab-test-readout
Analyse a finished A/B test and write the readout — the result, whether it's statistically and practically significant, what it means, and the ship/no-ship call. Use when asked to analyse experiment results, write an A/B test readout, interpret test data, or decide whether to ship a variant. Produces a clear verdict with the lift and confidence, segment cuts, the risks (peeking, novelty, sample), and a recommendation. Distinct from planning a test — this reads results.